The health ministry is expected to cut the official price of the drug by up to 15% from the current level of about ¥3 million ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope. “Alzheimer’s disease is a specific condition resulting from an abnormal biological ...

TAMPA, Fla. — The Food and Drug Administration has granted accelerated approval to the experimental drug lecanemab, shown to slow down the progression of Alzheimer’s disease in its early ...

Lecanemab has also been shown to successfully remove protein build-up from the brains of people living with early Alzheimer’s disease.

Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients new hope through MUSC's SCAN program ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

Following the news of two lecanemab-related deaths reported on the eve of the Clinical Trials on Alzheimer’s Disease (CTAD) 2022 conference, Eisai has now presented the full results from its ...

HATFIELD, HERTFORDSHIRE, UNITED KINGDOM (UK), and MAIDENHEAD, UK, 7 JULY 2025 – Eisai Europe Ltd. and Biogen Idec Ltd. announced today that the Scottish Medicines Consortium (SMC) has not recommended ...

THE NHS is failing to keep up with science, experts blasted after breakthrough new dementia drugs were rejected again by the regulator. Charities and scientists said patients are being left behind … ...

Two breakthrough Alzheimer's drugs cost too much and have too little benefit for NHS use, review finds.

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s by targeting a known cause, rather than just treating symptoms.

With promising drugs in the pipeline, we are on the cusp of "turning the tide" against Alzheimer's. But President Trump's plan to slash research spending could delay or halt progress for years, ...